Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorder With Chronic Direct Acting Antiviral Treatment
NCT02648022 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83
Last updated 2016-05-20
Summary
To determine the effect of an integrated care protocol on antiviral treatment and sustained virologic response (SVR) rates following initiation of direct acting antiviral therapies (DAA) treatments in 2011.
Conditions
- Hepatitis C
- Depression
- PTSD
- Substance Use Disorder
- Fibrosis
Interventions
- BEHAVIORAL
-
Brief mental health interventions and case management
The mental health practitioner (MHP) provided brief interventions and follow up sessions designed to reduce the risk factors that are barriers to successful antiviral treatment (substance use, depression, PTSD. Second, MHP provided ongoing case management services to these patients, with an emphasis on navigating the complex HCV care process, preparation for antiviral treatment, and managing the treatment process (adherence, side effects, etc). Third, the MHP also activated the patient and facilitate the medication management of depression and other psychiatric disorders when possible by collaborating with the prescribing HCV physicians.
Sponsors & Collaborators
-
VA Office of Research and Development
lead FED
Principal Investigators
-
Samuel B Ho, MD · VA San Diego Healthcare System, San Diego, CA
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2013-01-31
- Completion
- 2014-02-28
Countries
- United States
Study Locations
More Related Trials
-
Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes
NCT02650024 ·Status: COMPLETED
-
Study to Reduce Intravenous Exposures (STRIVE)
NCT00391482 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Patient-Centered Models of HCV Care for People Who Inject Drugs
NCT02824640 ·Status: COMPLETED ·Phase: NA
-
Intervention to Improve HCV Treatment Uptake and Adherence in HIV/HCV Coinfection
NCT02294136 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hepatitis C in Psychiatric Patients
NCT00751426 ·Status: COMPLETED
-
Hepatitis C Self-Management
NCT00328042 ·Status: COMPLETED ·Phase: NA
-
Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)
NCT03214679 ·Status: COMPLETED ·Phase: NA
-
Antiviral Pharmacology and Adherence in Drug Users
NCT02573376 ·Status: COMPLETED ·Phase: NA
-
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031 ·Status: COMPLETED ·Phase: PHASE4
-
Preventing Depression in Methadone Maintenance Patients Receiving Hepatitis C Treatment - 1
NCT00218556 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C in Severe Mental Disorders: Nursing Programme
NCT04891445 ·Status: COMPLETED ·Phase: NA
-
Hepatitis C Treatment in Underserved Populations
NCT01717560 ·Status: UNKNOWN ·Phase: NA
-
Reducing Depressive Symptoms During HCV Therapy: A Randomized Study
NCT00495768 ·Status: UNKNOWN ·Phase: NA
-
Toward Elimination of Hepatitis C Virus (HCV): A Pilot Study
NCT03364725 ·Status: UNKNOWN ·Phase: PHASE4
-
Puglia HCV Micro-elimination Program
NCT03923595 ·Status: COMPLETED
-
Overcoming Psychiatric Barriers to the Treatment of Hepatitis C
NCT00407732 ·Status: COMPLETED ·Phase: NA
-
Nurse Case Management to Improve Hepatitis C Care in HIV Co-infection
NCT02707991 ·Status: COMPLETED ·Phase: NA
-
Efficacy of an Exercise Intervention to Decrease Depressive Symptoms in Veterans With Hepatitis C
NCT00643695 ·Status: COMPLETED ·Phase: NA
-
Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
NCT02641158 ·Status: COMPLETED ·Phase: NA
-
Frequency of Anxiety and Depression in Chronic Hepatitis C Patients Recieving Direct-Acting Antiviral Agents
NCT03894696 ·Status: UNKNOWN
-
Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)
NCT01448915 ·Status: COMPLETED
-
Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China
NCT01647191 ·Status: COMPLETED ·Phase: NA
-
VBMI to Increase Treatment Completion With MK-MK-5172/MK-8742 Among Veterans With Active Substance Use Disorders Genotype 1 Chronic Hepatitis C
NCT02823457 ·Status: COMPLETED ·Phase: NA
-
Pilot Treatment as Prevention for HCV Among Persons Who Actively Inject Drugs
NCT02609893 ·Status: COMPLETED ·Phase: PHASE4
-
Integrated Treatment of Hepatitis C Virus Infection
NCT03155906 ·Status: COMPLETED ·Phase: NA